https://www.selleckchem.com/
orse clinical outcomes whenever biofilm infections are present. Further analyses are required to confirm these results before extending them to clinical practice. Adropin has been reported to be involved in metabolic disorders, including nonalcoholic fatty liver disease (NAFLD). However, the clinical relevance of adropin expression to the histological severity of NAFLD is unclear. This study aimed to investigate adropin expression in biopsy-proven NAFLD patients. This case-control study enrolled a total of 109 participants, including 15 normal histological
Like
Comment
Share
